Edition:
United Kingdom

Motif Bio PLC (MTFB.OQ)

MTFB.OQ on NASDAQ Stock Exchange Capital Market

8.90USD
20 Jun 2018
Change (% chg)

-- (--)
Prev Close
$8.90
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
834
52-wk High
$13.70
52-wk Low
$6.97

Chart for

About

Motif Bio plc is a clinical-stage biopharmaceutical company. The Company is engaged in development of antibiotics, which are designed for treatment of infections caused by multi-drug resistant bacteria. It operates in the development and commercialization of pharmaceutical formulations segment. The Company is focused on... (more)

Overall

Beta: --
Market Cap(Mil.): £118.90
Shares Outstanding(Mil.): 263.13
Dividend: --
Yield (%): --

Financials

  MTFB.OQ Industry Sector
P/E (TTM): -- 82.81 32.74
EPS (TTM): -0.28 -- --
ROI: -528.64 2.00 14.38
ROE: -541.44 3.49 16.08

BRIEF-Motif Bio Says 2017 Net Loss Widened To $44.8 Mln

* REPORTED A NET LOSS OF $44.8 MILLION FOR 2017 COMPARED TO A NET LOSS OF $40.3 MILLION IN 2016

10 Apr 2018

BRIEF-Motif Bio Announces Update On NDA Submission For Iclaprim

* ‍CO HAS DECIDED THAT IN ORDER TO ENSURE A COMPLETE AND HIGH QUALITY SUBMISSION, IT WOULD BE PRUDENT TO TAKE ADDITIONAL TIME​

20 Mar 2018

BRIEF-Motif Bio Says ‍Robert Dickey To Resign As CFO

* MOTIF BIO PLC - ‍ROBERT DICKEY IV HAS INFORMED COMPANY OF HIS INTENTION TO RESIGN FROM HIS ROLE AS CHIEF FINANCIAL OFFICER​

02 Feb 2018

BRIEF-Motif Bio Files For Mixed Shelf Of Up To $80 Million

* FILES FOR MIXED SHELF OF UP TO $80 MILLION - SEC FILING Source text: (http://bit.ly/2DqhH7L) Further company coverage:

18 Jan 2018

Earnings vs. Estimates